Published: 24 November 2017
Author(s): Mervat Mattar, Collaborators of the NEtwork for Drug Quality and Safety (NEDQAS)
Section: Letter to the Editor

Generic drugs (generics) are vital to the sustainability of health care systems, especially in developing areas with low resources. Ensuring benefit to patients through the approval and delivery of generics that meet quality standards remains essential. Generics are expected to be bioequivalent and interchangeable with the innovator's drug product's reference formulation. Aside from certain instances were such generics are found to be spurious, falsely-labelled, falsified, or counterfeit; all would have passed local regulatory approvals in manufacturing and importing countries before becoming available for patient prescription.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.